1,250
Participants
Start Date
June 24, 2020
Primary Completion Date
February 28, 2024
Study Completion Date
February 28, 2025
VIA and thermocoagulation
Participants will self-collect a vaginal brush for hr-HPV testing. HPV-positive women and every 10th consecutive HPV-negative woman will complete same-day VIA with colposcopically-directed cervical biopsy and ECC (if lesion seen), and thermocoagulation if ablation-eligible by colposcopy. If no lesion is seen on colposcopy, the woman will have a cervical pap smear and ECC collected, and no thermocoagulation will be performed. Finally, women who are suspicious for cancer at VIA will undergo colposcopically-directed cervical biopsies.
University of North Carolina (UNC) Project-Malawi, Lilongwe
National Cancer Institute (NCI)
NIH
United States Agency for International Development (USAID)
FED
UNC Lineberger Comprehensive Cancer Center
OTHER